Lindbrook Capital’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-87
| Closed | -$1.46K | – | 2915 |
|
|
2024
Q2 | $1.46K | Sell |
87
-73
| -46% | -$1.23K | ﹤0.01% | 2428 |
|
|
2024
Q1 | $2.4K | Buy |
160
+98
| +158% | +$1.47K | ﹤0.01% | 2173 |
|
|
2023
Q4 | $930 | Buy |
+62
| New | +$930 | ﹤0.01% | 2479 |
|
|
2021
Q4 | – | Sell |
-513
| Closed | -$9K | – | 2213 |
|
|
2021
Q3 | $9K | Buy |
513
+341
| +198% | +$5.98K | ﹤0.01% | 1055 |
|
|
2021
Q2 | $3K | Sell |
172
-106
| -38% | -$1.85K | ﹤0.01% | 1517 |
|
|
2021
Q1 | $5K | Sell |
278
-78
| -22% | -$1.4K | ﹤0.01% | 1276 |
|
|
2020
Q4 | $6K | Sell |
356
-13
| -4% | -$219 | ﹤0.01% | 1139 |
|
|
2020
Q3 | $7K | Sell |
369
-121
| -25% | -$2.3K | ﹤0.01% | 982 |
|
|
2020
Q2 | $13K | Buy |
490
+291
| +146% | +$7.72K | ﹤0.01% | 749 |
|
|
2020
Q1 | $4K | Sell |
199
-71
| -26% | -$1.43K | ﹤0.01% | 1122 |
|
|
2019
Q4 | $9K | Buy |
+270
| New | +$9K | ﹤0.01% | 958 |
|